Skip to main content
Fig. 2 | Journal of Negative Results in BioMedicine

Fig. 2

From: A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease

Fig. 2

Time-course of spirometry by treatment groups. Trend from baseline to week 12 (end of treatment), week 36 and week 60 (end of follow up period) for a) mean absolute FEV1, b) FEV1 percentage predicted, c) mean absolute FVC and d) FEV1/FVC, by treatment groups

Back to article page

Journal of Negative Results in BioMedicine

ISSN: 1477-5751

Contact us